Your browser doesn't support javascript.
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
Nyberg, Tommy; Harman, Katie; Zaidi, Asad; Seaman, Shaun R; Andrews, Nick; Nash, Sophie G; Charlett, Andre; Lopez Bernal, Jamie; Myers, Richard; Groves, Natalie; Gallagher, Eileen; Gharbia, Saheer; Chand, Meera; Thelwall, Simon; De Angelis, Daniela; Dabrera, Gavin; Presanis, Anne M.
  • Nyberg T; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Harman K; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Zaidi A; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Seaman SR; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Andrews N; Immunisation and Countermeasures Division, UK Health Security Agency, London, United Kingdom.
  • Nash SG; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Charlett A; National Infection Service, UK Health Security Agency, London, United Kingdom.
  • Lopez Bernal J; Immunisation and Countermeasures Division, UK Health Security Agency, London, United Kingdom.
  • Myers R; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Groves N; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Gallagher E; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Gharbia S; Genomics Programme, UK Health Security Agency, London, United Kingdom.
  • Chand M; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Thelwall S; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • De Angelis D; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Dabrera G; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Presanis AM; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
J Infect Dis ; 226(5): 808-811, 2022 09 13.
Article in English | MEDLINE | ID: covidwho-1758754
ABSTRACT
To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from non-AY.4.2 delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases in England based on linkage of routine health care datasets. Using stratified Cox regression, we estimated adjusted hazard ratios (aHR) of hospital admission (aHR = 0.85; 95% confidence interval [CI], .77-.94), hospital admission or emergency care attendance (aHR = 0.87; 95% CI, .81-.94), and COVID-19 mortality (aHR = 0.85; 95% CI, .71-1.03). The results indicate that the risks of hospitalization and mortality are similar or lower for AY.4.2 compared to cases with other delta sublineages.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Limits: Humans Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Limits: Humans Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis